In adults with diabetes who do not have advanced artery disease, a medication called evolocumab lowers the risk of dying from any cause over five years compared to a placebo.

We analyzed two assertions about evolocumab in adults with diabetes who do not have advanced artery disease, and both support the idea that this medication is linked to a lower risk of death over five years. In one case, the risk of dying from any cause dropped from 10.1% to 7.8% with evolocumab use [1]. In the other, the same reduction was seen when compared to a placebo [2]. Together, these two assertions suggest that, in this group of people, evolocumab may be associated with a meaningful drop in overall mortality risk. We did not find any studies or claims that contradict this pattern. However, it’s important to note that we only reviewed two assertions, and both come from the same general finding — a five-year reduction in death risk. We don’t have details on how the data was collected, who was included, or whether other factors like diet, exercise, or other medications were accounted for. We also don’t know if this benefit continues beyond five years or applies to all people with diabetes, or only specific subgroups. Evolocumab is a drug that lowers LDL cholesterol, often called “bad” cholesterol, by blocking a protein in the liver. Lowering LDL may help reduce the chance of heart problems, which are common in people with diabetes. But we don’t know if the drop in death risk is directly caused by lower cholesterol, or if other effects of the drug are involved. What we’ve found so far leans toward a benefit in reducing death risk over five years in adults with diabetes and no advanced artery disease. But because our analysis is based on only two assertions, and we lack deeper study details, we can’t say this is a guaranteed outcome for everyone. If you have diabetes and no known artery disease, and your doctor is considering evolocumab, it may be worth discussing whether this medication could help lower your long-term risk of death — but always consider your full health picture, not just one number.